Thomas Liggett
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
-
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
Papers in
- Oncology 6
- Cytokine Signaling Pathways and Interactions 3
- Lung Cancer Research Studies 1
-
- Multiple Sclerosis Research Studies 3
- Co-authors
- Anatoliy A. Melnikov (6 shared papers)Victor Levenson (6 shared papers)Qilong Yi (3 shared papers)Dusan Stefoski (5 shared papers)Roumen Balabanov (5 shared papers)Jeffrey R. Marks (1 shared paper)Karen Lynn Kaul (1 shared paper)Mark S. Talamonti (1 shared paper)
- Journals
- International Journal of Cancer (2 papers)The Journal of Immunology (1 paper)Journal of the Neurological Sciences (1 paper)Journal of Neuroimmunology (1 paper)Cell Cycle (1 paper)
- Partner nations
- United StatesItalyJapan
In The Last Decade
Thomas Liggett
12 papers receiving 596 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 276
- Oncology 170
- Pathology and Forensic Medicine 114
- Molecular Biology 341
- Reproductive Medicine 32
Countries citing papers authored by Thomas Liggett
This map shows the geographic impact of Thomas Liggett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Liggett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Liggett more than expected).
Fields of papers citing papers by Thomas Liggett
This network shows the impact of papers produced by Thomas Liggett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Liggett. The network helps show where Thomas Liggett may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Liggett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 113 | |
| 2 | 2010 | 101 | |
| 3 | 2010 | 85 | |
| 4 | 2011 | 79 | |
| 5 | 2010 | 61 | |
| 6 | 2012 | 59 | |
| 7 | 2012 | 37 | |
| 8 | 2011 | 30 | |
| 9 | 2011 | 25 | |
| 10 | 2009 | 11 | |
| 11 | 2010 | 9 | |
| 12 | 2010 | 3 |
About Thomas Liggett
Thomas Liggett is a scholar working on Oncology, Pathology and Forensic Medicine, Immunology, Cancer Research and Rheumatology, having authored 12 papers that have together received 613 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Cancer Genomics and Diagnostics (2 papers), interferon and immune responses (2 papers), Immune Response and Inflammation (2 papers), Epigenetics and DNA Methylation (2 papers), Systemic Lupus Erythematosus Research (2 papers) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Cancer Research (276 citations), Oncology (170 citations), Pathology and Forensic Medicine (114 citations), Molecular Biology (341 citations) and Reproductive Medicine (32 citations). Thomas Liggett has collaborated with scholars based in United States, Italy and Japan. Frequent co-authors include Anatoliy A. Melnikov, Victor Levenson, Qilong Yi, Dusan Stefoski, Roumen Balabanov, Jeffrey R. Marks, Karen Lynn Kaul, Mark S. Talamonti, Randall E. Brand and Qilong Yi. Their work appears in journals such as International Journal of Cancer, The Journal of Immunology, Journal of the Neurological Sciences, Journal of Neuroimmunology and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.